JNJ.BA
Johnson & Johnson
Buenos AiresARSEQUITY
Healthcare
DELAYED
Last price
28,700.00
▲ 360.00 (1.27%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
28,340.00
Prev close
28,340.00
Day high
28,840.00
Day low
28,200.00
Volume
16.68K
Market cap
$345.58T
P/E (TTM)
11.12
52W range
15,475.00 – 29,420.00
Day trading desk
Gap from prior close
0.00%
Prior close 28,340.00
VWAP
28,706.25
-0.02% from price
Relative volume
2.55×
Unusually busy
Session range
1.76%
28,340.00 – 28,840.00
Position in range
72%
Near session high
ATR (14D)
560.00
1.95% of price
Prior day high
28,760.00
PDH
Prior day low
28,260.00
PDL
Bid / ask spread
—
Quote not published
Session volume
33.00K
Avg 12.95K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+4.67%
+6.0%
1M
+4.97%
+1.2%
3M
+25.66%
+22.6%
6M
+21.51%
+10.4%
YTD
+36.47%
+24.2%
1Y
+86.36%
+66.4%
3Y
+360.82%
+286.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on JNJ.BA open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
0
Total on file
Fundamentals
Market cap$345.58T
Enterprise value$1032.33T
Revenue (TTM)$97.93B
Gross profit$66.73B
EBITDA$34.87B
Net income$21.04B
EPS (TTM)$2,580.13
Free cash flow$16.89B
Total cash$20.76B
Total debt$49.04B
Book value / share$3,533.67
Shares outstanding12.05B
Float35.91B
Short % of float—
Dividend yield1.77%
Beta (5Y)0.23
Valuation & profitability ratios
Trailing P/E11.12
Forward P/E—
PEG ratio1.68
Price / sales—
Price / book8.12
EV / revenue10,541.60
EV / EBITDA29,603.35
Gross margin68.14%
Operating margin29.19%
Profit margin21.48%
Return on equity25.74%
Return on assets8.60%
Debt / equity57.71
Current ratio1.09
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $94.19B | $88.82B | $85.16B | $79.99B | +6.0% |
| Operating revenue | $94.19B | $88.82B | $85.16B | $79.99B | +6.0% |
| Cost of revenue | $30.26B | $27.47B | $26.55B | $24.60B | +10.1% |
| Gross profit | $63.94B | $61.35B | $58.61B | $55.39B | +4.2% |
| Research & development | $14.66B | $17.23B | $15.09B | $14.13B | -14.9% |
| Selling, general & admin | $23.68B | $22.87B | $21.51B | $20.25B | +3.5% |
| Total operating expense | $38.34B | $40.10B | $36.60B | $34.38B | -4.4% |
| Operating income | $25.60B | $21.25B | $22.01B | $21.01B | +20.5% |
| Net interest income | $85.00M | $577.00M | $489.00M | $214.00M | -85.3% |
| Pre-tax income | $32.58B | $16.69B | $15.06B | $19.36B | +95.2% |
| Tax provision | $5.78B | $2.62B | $1.74B | $2.99B | +120.4% |
| Net income | $26.80B | $14.07B | $35.15B | $17.94B | +90.6% |
| Net income to common | $26.80B | $14.07B | $35.15B | $17.94B | +90.6% |
| Basic EPS | 2.23 | 1.17 | 2.92 | 1.37 | +90.5% |
| Diluted EPS | 2.21 | 1.16 | 2.74 | 1.35 | +90.5% |
| EBIT | $33.55B | $17.44B | $15.83B | $19.64B | +92.4% |
| EBITDA | $41.05B | $24.78B | $23.32B | $26.61B | +65.7% |
| Basic shares | 12.04B | 12.03B | 12.04B | 13.07B | +0.0% |
| Diluted shares | 12.15B | 12.15B | 12.80B | 13.32B | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $19.71B | $24.11B | $21.86B | $12.89B | — | -18.2% |
| Cash & short-term investments | $20.10B | $24.52B | $22.93B | $22.28B | — | -18.0% |
| Accounts receivable | $17.18B | $14.84B | $14.87B | $14.04B | — | +15.7% |
| Inventory | $14.19B | $12.44B | $11.18B | $10.27B | — | +14.0% |
| Total current assets | $55.62B | $55.89B | $53.49B | $55.29B | — | -0.5% |
| Property, plant & equipment | $23.17B | $20.52B | $19.90B | $17.98B | — | +12.9% |
| Goodwill & intangibles | $99.17B | $81.82B | $70.73B | $74.54B | — | +21.2% |
| Total assets | $199.21B | $180.10B | $167.56B | $187.38B | — | +10.6% |
| Total current liabilities | $54.13B | $50.32B | $46.28B | $55.80B | — | +7.6% |
| Current debt | $8.49B | $5.98B | $3.45B | $12.76B | — | +42.0% |
| Long-term debt | $39.44B | $30.65B | $25.88B | $26.89B | — | +28.7% |
| Total debt | $47.93B | $36.63B | $29.33B | $39.64B | — | +30.8% |
| Total liabilities | $117.67B | $108.61B | $98.78B | $110.57B | — | +8.3% |
| Retained earnings | — | — | $153.84B | $128.34B | $123.06B | — |
| Shareholder equity | $81.54B | $71.49B | $68.77B | $76.80B | — | +14.1% |
| Working capital | $1.50B | $5.57B | $7.21B | -$508.00M | — | -73.1% |
| Net tangible assets | -$17.63B | -$10.33B | -$1.96B | $2.27B | — | -70.7% |
| Shares issued | 3.12B | 3.12B | 3.12B | 3.12B | — | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $26.80B | $14.07B | $35.15B | $17.94B | +90.6% |
| Depreciation & amortisation | $7.50B | $7.34B | $7.49B | $6.97B | +2.2% |
| Stock-based compensation | $1.35B | $1.18B | $1.16B | $1.14B | +15.1% |
| Change in working capital | -$12.72B | $1.84B | $2.51B | -$4.01B | -792.3% |
| Operating cash flow | $24.53B | $24.27B | $22.79B | $21.19B | +1.1% |
| Capital expenditure | -$5.22B | -$6.21B | -$5.01B | -$4.01B | +15.9% |
| Investing cash flow | -$23.59B | -$18.60B | $878.00M | -$12.37B | -26.8% |
| Share buybacks | -$5.95B | -$2.43B | -$5.05B | -$6.04B | -144.8% |
| Dividends paid | -$12.38B | -$11.82B | -$11.77B | -$11.68B | -4.7% |
| Financing cash flow | -$5.54B | -$3.13B | -$15.82B | -$8.87B | -76.9% |
| Free cash flow | $19.31B | $18.06B | $17.78B | $17.18B | +6.9% |
| End cash position | $19.71B | $24.11B | $21.86B | $14.13B | -18.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $25.31B | $24.06B | $24.56B | $23.99B | $23.74B | — | +5.2% |
| Operating revenue | $25.31B | $24.06B | $24.56B | $23.99B | $23.74B | — | +5.2% |
| Cost of revenue | $8.05B | $8.11B | $7.97B | $7.30B | $7.63B | — | -0.7% |
| Gross profit | $17.26B | $15.96B | $16.60B | $16.69B | $16.11B | — | +8.2% |
| Research & development | $3.65B | $3.53B | $4.25B | $3.67B | $3.52B | — | +3.6% |
| Selling, general & admin | $6.43B | $6.03B | $6.75B | $5.92B | $5.89B | — | +6.6% |
| Total operating expense | $10.09B | $9.56B | $11.01B | $9.59B | $9.40B | — | +5.5% |
| Operating income | $7.17B | $6.39B | $5.59B | $7.10B | $6.71B | — | +12.2% |
| Net interest income | -$62.00M | -$43.00M | $23.00M | -$18.00M | -$48.00M | — | -44.2% |
| Pre-tax income | $6.75B | $5.99B | $4.97B | $7.49B | $6.49B | — | +12.6% |
| Tax provision | $1.21B | $755.00M | -$150.00M | $2.34B | $954.00M | — | +60.7% |
| Net income | $5.53B | $5.24B | $5.12B | $5.15B | $5.54B | — | +5.7% |
| Net income to common | $5.53B | $5.24B | $5.12B | $5.15B | $5.54B | — | +5.7% |
| Basic EPS | 0.46 | 0.43 | 0.42 | 0.43 | 0.46 | — | +5.9% |
| Diluted EPS | 0.45 | 0.43 | 0.42 | — | 0.46 | 0.91 | +6.1% |
| EBIT | $7.03B | $6.26B | $5.18B | $7.74B | $6.80B | — | +12.2% |
| EBITDA | $8.99B | $8.27B | $7.19B | $9.52B | $8.74B | — | +8.7% |
| Basic shares | 12.04B | 12.04B | 12.04B | 12.04B | 12.03B | — | -0.0% |
| Diluted shares | 12.20B | 12.23B | 12.20B | — | 12.10B | 12.12B | -0.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $20.42B | $21.69B | $19.71B | $18.23B | $18.58B | -5.8% |
| Cash & short-term investments | $20.76B | $22.05B | $20.10B | $18.56B | $18.88B | -5.9% |
| Accounts receivable | $19.05B | $17.72B | $17.18B | $17.61B | $17.85B | +7.5% |
| Inventory | $15.14B | $14.58B | $14.19B | $14.15B | $13.41B | +3.8% |
| Total current assets | $59.77B | $59.17B | $55.62B | $54.61B | $54.50B | +1.0% |
| Property, plant & equipment | $23.58B | $23.27B | $23.17B | $22.34B | $21.95B | +1.3% |
| Goodwill & intangibles | $96.71B | $97.62B | $99.17B | $96.78B | $97.95B | -0.9% |
| Total assets | $201.06B | $200.89B | $199.21B | $192.82B | $193.39B | +0.1% |
| Total current liabilities | $54.90B | $57.72B | $54.13B | $50.87B | $54.18B | -4.9% |
| Current debt | $11.69B | $17.46B | $8.49B | $6.39B | $11.53B | -33.0% |
| Long-term debt | $37.34B | $37.53B | $39.44B | $39.41B | $39.23B | -0.5% |
| Total debt | $49.04B | $54.99B | $47.93B | $45.80B | $50.76B | -10.8% |
| Total liabilities | $116.09B | $119.71B | $117.67B | $113.54B | $114.92B | -3.0% |
| Shareholder equity | $84.97B | $81.19B | $81.54B | $79.28B | $78.47B | +4.7% |
| Working capital | $4.88B | $1.46B | $1.50B | $3.74B | $318.00M | +234.9% |
| Net tangible assets | -$11.74B | -$16.43B | -$17.63B | -$17.51B | -$19.48B | +28.6% |
| Shares issued | 2.41B | 3.12B | 3.12B | 3.12B | 3.12B | -22.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $5.53B | $5.24B | $5.12B | $5.15B | $5.54B | +5.7% |
| Depreciation & amortisation | $1.96B | $2.00B | $2.01B | $1.78B | $1.94B | -2.2% |
| Stock-based compensation | $458.00M | $300.00M | $309.00M | $347.00M | $410.00M | +52.7% |
| Change in working capital | $1.02B | -$5.23B | $3.60B | -$369.00M | -$4.92B | +119.5% |
| Operating cash flow | $8.62B | $2.51B | $7.31B | $9.17B | $3.88B | +242.7% |
| Capital expenditure | -$1.32B | -$1.05B | -$1.84B | -$1.17B | -$1.40B | -25.9% |
| Investing cash flow | -$1.11B | -$1.04B | -$4.49B | -$542.00M | -$18.26B | -6.7% |
| Share buybacks | -$221.00M | -$4.03B | -$1.92B | -$1.90B | $0 | +94.5% |
| Dividends paid | -$3.23B | -$3.13B | -$3.13B | -$3.13B | -$3.13B | -3.1% |
| Financing cash flow | -$8.78B | $530.00M | -$1.37B | -$8.93B | -$5.67B | -1,756.0% |
| Free cash flow | $7.29B | $1.47B | $5.47B | $8.00B | $2.48B | +398.0% |
| End cash position | $20.42B | $21.69B | $19.71B | $18.23B | $18.58B | -5.8% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $25.19B | +5.0% |
| Next quarter | — | — | $26.56B | +8.1% |
| Current year | — | — | $101.12B | +7.4% |
| Next year | — | — | $108.77B | +7.6% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.00%
Held by institutions0.06%
Institutions holding2
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
27,940.00
+2.72% from price
SMA 20
27,650.00
+3.80% from price
SMA 50
26,685.20
+7.55% from price
SMA 100
24,791.40
+15.77% from price
SMA 200
23,400.00
+22.65% from price
EMA 12
27,959.47
+2.65% from price
EMA 26
27,464.36
+4.50% from price
EMA 50
26,657.60
+7.66% from price
RSI (14)
64.1
Neutral
MACD (12,26,9)
495.11
Hist 76.97
ATR (14)
560.00
1.95% of price
Realised vol 30D
27.3%
Annualised
Bollinger upper
28,939.31
20, 2σ
Bollinger lower
26,360.69
20, 2σ
50 / 200 cross
Golden
26,685.20 vs 23,400.00
Trend bias
Above 200
+22.65%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.33
Less volatile than market
Correlation to SPY
-0.15
Largely independent
Realised vol 30D
27.3%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-11.4%
Peak to trough
Max drawdown 5Y
-67.7%
Peak to trough
ATR 14
560.00
1.95% of price
Beta (reported)
0.23
5Y monthly, from filing
Dividends & splits
Forward rate$508.64 / yr
Forward yield1.77%
5-year avg yield1.66%
Payout ratio20.26%
Ex-dividend dateAug 25, 2026
Next pay date—
Last split—
Split date—
Headlines
Amorim starts Serie A life with Milan win, Juve edge Frosinone
AFP · 12m ago
Lawsuit filed in Napali coast ‘doors-off’ helicopter tour crash
The Honolulu Star-Advertiser · 12m ago
Does Billionaire Bill Ackman Know Something Wall Street Doesn’t? He Invested in These 2 Stocks That Have Dropped 33% and 18% Over the Past Year
Motley Fool · 13m ago
Liquor industry struggles grow with another Chapter 7 filing
TheStreet · 15m ago
Raphinha, Lopez hit braces as Barcelona trounce Elche
AFP · 15m ago
Media Advisory: Housing Announcement in Toronto
CNW Group · 18m ago
Dow Jones Futures Due With Market At Key Point; Nvidia, Tariffs, Warsh In Focus
Investor's Business Daily · 24m ago
Axsome Therapeutics Stock Is Up 16% Year to Date. Why Wall Street Thinks It Has Even More Room to Run
Motley Fool · 28m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.